Also, the buy-back program should resume next Monday as the blackout period ends today.
- Forums
- ASX - By Stock
- NEU
- Ann: 2024 results - A$166m comprehensive income for shareholders
NEU
neuren pharmaceuticals limited
Add to My Watchlist
10.1%
!
$13.80

Ann: 2024 results - A$166m comprehensive income for shareholders, page-6
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$13.80 |
Change
1.260(10.1%) |
Mkt cap ! $1.730B |
Open | High | Low | Value | Volume |
$12.96 | $14.00 | $12.91 | $9.251M | 676.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
12 | 520 | $13.79 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.81 | 74 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 165 | 13.780 |
1 | 387 | 13.770 |
3 | 479 | 13.760 |
4 | 2437 | 13.750 |
4 | 1214 | 13.740 |
Price($) | Vol. | No. |
---|---|---|
13.800 | 565 | 9 |
13.810 | 214 | 4 |
13.820 | 624 | 5 |
13.830 | 491 | 5 |
13.840 | 508 | 5 |
Last trade - 12.09pm 26/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online